Hand-held Surgical Instruments Market Size - By Product (Forceps, Retractors, Graspers, Scalpels, Cannulas), By Application (Orthopedic Surgery, Cardiology, Ophthalmology, Wound Care, Urology & Gynecology Surgery), By End-use, & Forecast, 2023 – 2032

Hand-held Surgical Instruments Market Size

Hand-held surgical instruments market size was valued at over USD 5.5 billion in 2022 and is projected to reach around USD 11.2 billion by 2032. This incremental growth rate is owing to increasing prevalence of chronic diseases coupled with rising number of surgical procedures associated with these ailments.
 

Technological advancements pertaining to hand-held surgical instruments has accelerated the product adoption rate in several healthcare facilities for a variety of surgical procedures. Increasing focus on patient safety and surgical efficiency has augmented the product acceptance rate globally. Increasing surgical procedures worldwide, driven by the rising prevalence of chronic diseases and the aging population have proven beneficial for the market expansion.
 

Additionally, technological advancements have played a crucial role in the growth of the hand-held surgical instruments industry. Advancements in hand-held surgical instruments have aid in minimally invasive surgery, robotic-assisted surgery, and energy-based devices, enhancing surgical outcomes and patient recovery. Growing healthcare infrastructure, particularly in developing countries, leading to an increased number of hospitals and surgical centers. Rising disposable incomes and healthcare expenditure enables greater affordability of surgical procedures in several countries globally. Thus, increasing investments, focus on patient safety & surgical efficiency, and government initiatives are driving the adoption of advanced hand-held surgical instruments.
 

However, availability of alternative treatment methods can pose a significant challenge and impede the market progress. Advances in medical technology have led to the development of non-surgical and minimally invasive treatment options. These alternatives, such as laser therapy, robotic-assisted surgery, or image-guided interventions, aim to reduce the need for traditional surgical procedures that require hand-held instruments. As these alternatives become more effective and widely adopted, they may limit the growth of the market.
 

Pharmaceutical interventions, such as targeted therapies or pharmacological treatments, can replace the need for surgical procedures. These alternatives are constantly evolving, and they may provide less invasive or non-invasive options for patients, further reducing the demand for hand-held surgical instruments. the availability of alternative treatment methods can potentially restrain the market demand, the continued need for surgical procedures and the unique benefits provided by these instruments are expected to sustain their demand to a significant extent.
 

COVID-19 Impact

The recent outbreak of COVID-19 had negatively influenced the hand-held surgical instruments market revenue, specifically during the initial phase of 2020. The coronavirus outbreak proliferated the disease burden and hampered several global businesses including the healthcare sector, during the pandemic phase. These conditions severely impacted the market growth. Several hospitals and healthcare facilities globally experienced a significant decline in patient visits for diagnosis and treatment of chronic conditions. Non-urgent medical procedures and surgical operations were postponed or canceled to prioritize resources for COVID-19 patients. To prioritize resources and reduce the risk of virus transmission, many healthcare facilities had to postpone or cancel elective surgeries during the pandemic. The decline in elective procedures led to a decrease in demand for these instruments, impacting market share.
 

The outbreak of COVID-19 pandemic caused disruptions in global supply chains, affecting the production, distribution, and availability of medical devices, including hand-held surgical instruments. Lockdowns, travel restrictions, and reduced manufacturing capacities led to delays and shortages, hindering the market's growth. The pandemic accelerated the adoption of telemedicine and non-surgical treatment options, as they allowed for remote consultations and reduced the need for in-person visits. These alternatives, which often do not require hand-held surgical instruments, gained prominence during the pandemic, leading to a temporary reduction in demand for such instruments.
 

Hand-held Surgical Instruments Market Trends

Increasing prevalence of chronic diseases is expected to drive the market size. Chronic diseases, such as cardiovascular diseases, cancer, diabetes, and orthopedic conditions, continue to pose a significant health burden worldwide. For instance, according to the WHO data, in 2021, around 422 million people worldwide were suffering from diabetes and is estimated to increase in the near future. This rising instance of chronic ailment has augmented the in-patient hospitalization for surgical interventions and augmenting the market trends. Factors such as aging populations, sedentary lifestyles, and changing dietary patterns contribute to the increasing prevalence of these conditions. Surgical interventions are often required for the diagnosis, treatment, and management of chronic diseases, driving the demand for hand-held surgical instruments.
 

Additionally, management of chronic diseases require surgical interventions at various stages of diagnosis and treatment. For instance, cardiovascular diseases may necessitate procedures such as coronary artery bypass grafting or cardiac catheterization, while cancer treatments often involve surgeries for tumour removal or biopsies. Hand-held surgical instruments play a crucial role in these procedures, enabling surgeons to perform precise and controlled maneuvers. Expanding healthcare infrastructure, particularly in emerging markets, is creating greater accessibility to surgical interventions for chronic diseases.
 

Hand-held Surgical Instruments Market Analysis

Based on product, the market is segmented as forceps, retractors, dilators, graspers, scalpels, cannulas and others. The forceps segment dominated the hand-held surgical instruments market accounting over 24% business share in 2022. Forceps are surgical instrument with two opposing blades or pincers used for grasping, holding, or manipulating tissues, organs, or other surgical materials. Forceps allow surgeons to grasp and manipulate tissues with precision and control. They provide a firm grip on delicate structures, enabling surgeons to hold and move tissues without causing excessive trauma or damage. This capability is especially important in procedures where precise tissue handling is crucial, such as in microsurgery or delicate organ surgeries. These instruments can help create planes, expose anatomical structures, or dissect tissues without the need for additional instruments.
 

Forceps with sharp tips or serrated jaws are particularly useful for controlled dissection, minimizing bleeding and tissue trauma. Forceps are designed with fine, serrated jaws or interlocking teeth that enable effective hemostasis. Surgeons can use these forceps to clamp blood vessels, secure small bleeders, or control bleeding during procedures. These instruments act as an extension of the surgeon's hand, assisting in the manipulation of other surgical instruments or materials. They can be used to hold, stabilize, or reposition instruments, sutures, or grafts, enhancing surgical dexterity and facilitating complex procedures.
 

Based on application, the hand-held surgical instruments market is segmented as orthopedic surgery, cardiology, ophthalmology, wound care, urology and gynecology surgery, plastic surgery, neurosurgery and others. The orthopedic surgery segment held a dominant market share accounting over USD 1.2 billion in 2022.  Increasing prevalence of orthopedic ailments has increased the number of surgical procedures over the recent years. For instance, according to the OECD data, in 2021, around 260 knee replacement surgeries per 100,000 population were performed in Germany. Orthopedic procedures often require precise manipulation of bones, joints, and soft tissues. Hand-held surgical instruments offer surgeons the ability to perform precise surgical interventions. These instruments provide control over the amount of force applied, enabling surgeons to achieve accurate bone alignment, implant placement, and tissue preparation.
 

Hand-held surgical instruments minimize tissue trauma and preserve surrounding structures during orthopedic surgeries. These instruments are vital in the placement and fixation of orthopedic implants, such as screws, plates, and nails. Instruments such as shavers, probes, and forceps assist in accessing and visualizing joint structures during arthroscopy. They facilitate tissue debridement, removal of loose bodies, and repair of damaged cartilage or ligaments, helping to restore joint function and alleviate pain. Therefore, hand-held surgical instruments are indispensable in orthopedic surgery, providing precise control, tissue preservation, implant fixation, soft tissue management, and supporting minimally invasive techniques thereby fuelling the market share.
 

Based on end-use, the hand-held surgical instruments market is segmented as hospitals, clinics, ambulatory surgical centers and others. The hospitals segment held a majority market share and is expected to grow at 7.5% CAGR by 2032. Increasing prevalence of chronic ailments coupled with technological advancements in hand-held surgical instruments is anticipated to drive the product adoption rate in hospitals. Hand-held surgical instruments have expanded the surgical capabilities of hospitals, allowing them to offer a broader range of procedures. Hospitals can provide a comprehensive range of surgical services and are better equipped to attract patients and meet the healthcare needs. Availability of advance hand-held surgical instruments to perform variety of surgical procedures as well as favorable reimbursement policies in hospital settings will surge the segment revenue.
 

Furthermore, factors such as increase in the number of surgical procedures and the availability of highly skilled healthcare professionals coupled with robust healthcare infrastructure and appropriate patient assistance that are propelling the growth of the hospitals segment positively. The increasing demand for hospitals to provide the advancements and benefits offered by hand-held surgical instruments is driven by the pursuit of improved patient outcomes, technological advancements, expanded surgical capabilities, surgeon preferences, and patient expectations. As a result, hospitals are increasingly investing in these instruments to offer high-quality surgical care, access to better treatment and diagnosis thus propelling segment demand.
 

North America region held a dominant share in the hand-held surgical instruments market and was valued at USD 2.2 billion in 2022. Increasing diseases burden of chronic ailments, such as cardiovascular diseases, cancer, diabetes, and orthopedic conditions among others is expected to drive the market size. Surgical interventions are often required for the diagnosis, treatment, and management of these diseases. Hand-held surgical instruments play a crucial role in performing precise surgical procedures, driving the demand for these instruments. Hand-held instruments designed for minimally invasive procedures have gained popularity in North America due to their benefits, including smaller incisions, reduced scarring, shorter hospital stays, and faster recovery times.
 

Favorable reimbursement policies for surgical procedures encourage hospitals and healthcare facilities to invest in advanced surgical instruments, including hand-held instruments. This reimbursement support stimulates the demand for these instruments in the region. Thus, increasing demand for hand-held surgical instruments in North America can be attributed to technological advancements, increasing prevalence of chronic diseases, supporting initiatives aimed at improving healthcare outcomes, aging population, favorable reimbursement policies, and surgeon preferences among others.
 

Hand-held Surgical Instruments Market Share

Some of the major players operating in the hand-held surgical instruments market are:

• Aspen Surgical
• B. Braun Melsungen AG
•  Becton
•  Dickinson and Company
•  Cook Medical LLC
•  CooperSurgical Inc.
•  Integra LifeSciences Corporation
•  Johnson & Johnson Inc
•  KLS Martin
•  Medtronic plc
•  Olympus Corporation
•  Richard Wolf GmbH
•  Smith & Nephew
•  Teleflex Incorporated
•  Thompson Surgical Instruments Inc
•  Zimmer Biomet Holdings

These leading market players are implementing advanced technologies to cater to the large unmet needs of the consumers. These players focus on strategic partnerships, new product launch & commercialization for market expansion.
 

Hand-held Surgical Instruments Industry Leaders:

• In August 2021, Ethicon a subsidiary of Johnson & Johnson announced the launch of ECHELON CIRCULAR Powered Stapler, a hand-held surgical stapler. This device is incorporated with 3D stapling and gripping surface technology. This innovative product launch helped the company to enhance their customer base and gain a competitive edge over its peers.
   
• In January 2021, Smith+Nephew announced the acquisition of Integra LifeSciences Holdings Corporation, a manufacturer of medical and surgical devices including hand-held surgical instruments. This acquisition helped the company to expand their business and product offering in orthopedic segment. This strategic move helped the company to enhance their product portfolio and increase their business revenue.
   

Hand-held surgical instruments market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue (USD Million) and volume (units) from 2018 to 2032, for the following segments:

Click here to Buy Section of this Report

By Product, 2018 - 2032 (USD Million & Units)

• Forceps
• Retractors
• Dilators
• Graspers
• Scalpels
• Cannulas
• Others 

By Application, 2018 - 2032 (USD Million)

• Orthopedic Surgery
• Cardiology
• Ophthalmology
• Wound Care
• Urology and Gynecology Surgery
• Plastic Surgery
• Neurosurgery
• Others

By End-use, 2018 - 2032 (USD Million)

• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Others

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Poland
  • Sweden
  • The Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Indonesia
  • Thailand
  • Philippines
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Chile
  • Peru
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Egypt
  • Turkey